Blue Water Life Science Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-78,843
Closed -$4.43M – 8
2024
Q4
$4.43M Sell
78,843
-176,400
-69% -$11M 3.92% 7
2024
Q3
$17.4M Buy
255,243
+197,900
+345% +$11.2M 15.29% 3
2024
Q2
$2.42M Hold
57,343
– – 2.36% 7
2024
Q1
$3.96M Buy
+57,343
New +$3.63M 3.72% 7
2021
Q2
– Sell
-166,957
Closed -$22M – 25
2021
Q1
$22M Buy
166,957
+91,707
+122% +$12.6M 10.75% 5
2020
Q4
$9.97M Buy
+75,250
New +$9.1M 5.85% 9

Other funds holding EXAS

Blue Water Life Science Advisors's EXAS Position: Q1 2025 in Review

Blue Water Life Science Advisors sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 78,843 shares — an estimated $4.43M sold.

Blue Water Life Science Advisors first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $22M in Q1 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Blue Water Life Science Advisors reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 78,843 Exact Sciences shares in Q1 2025, an estimated $4.43M.
  • Blue Water Life Science Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Blue Water Life Science Advisors's Exact Sciences position peaked at $22M in Q1 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2025, filed 15 May 2025.